Pamir Ozan bought NAGE
November 14, 2025 · Form 4 insider transaction
Pamir Ozan bought 2,220 shares of Niagen Bioscience, Inc. at $6.85 per share, a transaction worth $15.2K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,220
Price
$6.85
Total value
$15.2K
InsiderPamir Ozan
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 14, 2025
Filing dateNovember 17, 2025
Shares owned after2,220
OwnershipIndirect
10b5-1 planNo
AmendedNo